RecruitingNot Applicable

Prevalence of FGIDs and Probiotics Study

Thailand512 participantsStarted 2024-03-14

Plain-language summary

This is a study to evaluate the prevalence of FGIDs in infants using the Thai version of Rome IV diagnostic questionnaire for functional gastrointestinal disorders in infants and evaluate the efficacy of Limosilactobacillus reuteri DSM 17938 to prevent FGIDs in infants.

Who can participate

Age range3 Days – 1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy and term (GA 37-41 weeks) infants
✓. Appropriate weight for age
✓. APGAR score more than 8 at 10 minutes of life
✓. Normal physical examination
✓. Mothers have no previous probiotics use

Exclusion criteria

✕. not willing to anticipate in the study
✕. cannot come to follow-up until 1 year of age

What they're measuring

The prevalence of functional gastrointestinal disorders in the treatment group

Timeframe: at birth, 1 month, 2 months, 4 months

Trial details

NCT IDNCT06309199

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02

Contact for this trial

Palittiya Sintusek, PhD

+66818288082 palittiya.s@chula.ac.th

View on ClinicalTrials.gov More Functional Gastrointestinal Disorders trials